HIV-1 Accessory Proteins—Ensuring Viral Survival in a Hostile Environment

An, 2007, Polymorphisms of CUL5 are associated with CD4+ T cell loss in HIV-1 infected individuals, PLoS Genet., 3, e19, 10.1371/journal.pgen.0030019 Andersen, 2006, HIV-1 Vpr-induced apoptosis is cell cycle dependent and requires Bax but not ANT, PLoS Pathog., 2, e127, 10.1371/journal.ppat.0020127 Atkins, 2008, HIV-1 Nef binds PACS-2 to assemble a multi-kinase cascade that triggers MHC-I downregulation: Analysis using siRNA and knockout mice, J. Biol. Chem., 283, 11,772, 10.1074/jbc.M707572200 Bannert, 2004, Retroelements and the human genome: new perspectives on an old relation, Proc. Natl. Acad. Sci. USA, 101, 14572, 10.1073/pnas.0404838101 Bartee, 2006, Quantitative membrane proteomics reveals new cellular targets of viral immune modulators, PLoS Pathog., 2, e107, 10.1371/journal.ppat.0020107 Belzile, 2007, HIV-1 Vpr-Mediated G2 Arrest Involves the DDB1–CUL4A(VPRBP) E3 Ubiquitin Ligase, PLoS Pathog., 3, e85, 10.1371/journal.ppat.0030085 Binette, 2007, Requirements for the selective degradation of CD4 receptor molecules by the human immunodeficiency virus type 1 Vpu protein in the endoplasmic reticulum, Retrovirology, 4, 75, 10.1186/1742-4690-4-75 Bogerd, 2008, Single-stranded RNA facilitates nucelocapsid:APOBEC3G complex formation, RNA, 14, 1228, 10.1261/rna.964708 Bolton, 2007, Vpr cytopathicity independent of G2/M cell cycle arrest in human immunodeficiency virus type 1-infected CD4+ T cells, J. Virol., 81, 8878, 10.1128/JVI.00122-07 Bour, 1996, The human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV type 1 Vpu that enhances particle release of heterologous retroviruses, J. Virol., 70, 8285, 10.1128/JVI.70.12.8285-8300.1996 Brass, 2008, Identification of host proteins required for HIV infection through a functional genomic screen, Science, 319, 921, 10.1126/science.1152725 Brenner, 2006, Importance of the N-distal AP-2 binding element in Nef for simian immunodeficiency virus replication and pathogenicity in rhesus macaques, J. Virol., 80, 4469, 10.1128/JVI.80.9.4469-4481.2006 Chaudhuri, 2007, Downregulation of CD4 by human immunodeficiency virus type 1 Nef is dependent on clathrin and involves direct interaction of Nef with the AP2 clathrin adaptor, J. Virol., 81, 3877, 10.1128/JVI.02725-06 Chen, 2006, APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons, Curr. Biol., 16, 480, 10.1016/j.cub.2006.01.031 Chiu, 2005, Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells, Nature, 435, 108, 10.1038/nature03493 Chiu, 2006, High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition, Proc. Natl. Acad. Sci. USA, 103, 15588, 10.1073/pnas.0604524103 Conticello, 2005, Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases, Mol. Biol. Evol., 22, 367, 10.1093/molbev/msi026 Deacon, 1995, Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients, Science, 270, 988, 10.1126/science.270.5238.988 Dehart, 2008, Human immunodeficiency virus type 1 Vpr links proteasomal degradation and checkpoint activation, J. Virol., 82, 1066, 10.1128/JVI.01628-07 DeHart, 2007, HIV-1 Vpr activates the G2 checkpoint through manipulation of the ubiquitin proteasome system, Virol. J., 4, 57, 10.1186/1743-422X-4-57 Derse, 2007, Resistance of human T cell leukemia virus type 1 to APOBEC3G restriction is mediated by elements in nucleocapsid, Proc. Natl. Acad. Sci. USA, 104, 2915, 10.1073/pnas.0609444104 Esnault, 2005, APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses, Nature, 433, 430, 10.1038/nature03238 Fenard, 2005, Nef is physically recruited into the immunological synapse and potentiates T cell activation early after TCR engagement, J. Immunol., 175, 6050, 10.4049/jimmunol.175.9.6050 Gaddis, 2004, Further investigation of simian immunodeficiency virus Vif function in human cells, J. Virol., 78, 12041, 10.1128/JVI.78.21.12041-12046.2004 Gallois-Montbrun, 2008, Comparison of cellular ribonucleoprotein complexes associated with the APOBEC3F and APOBEC3G antiviral proteins, J. Virol., 82, 5636, 10.1128/JVI.00287-08 Gallois-Montbrun, 2007, Antiviral protein APOBEC3G localizes to ribonucleoprotein complexes found in P bodies and stress granules, J. Virol., 81, 2165, 10.1128/JVI.02287-06 Geleziunas, 2001, HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell, Nature, 410, 834, 10.1038/35071111 Goh, 1998, HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo, Nat. Med., 4, 65, 10.1038/nm0198-065 Gonzalez, 2003, Viroporins, FEBS Lett., 552, 28, 10.1016/S0014-5793(03)00780-4 Gordon, 2008, Short-lived infected cells support virus replication in naturally SIV-infected sooty mangabeys: implications for AIDS pathogenesis, J. Virol., 82, 3725, 10.1128/JVI.02408-07 Gottlinger, 1993, Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses, Proc. Natl. Acad. Sci. USA, 90, 7381, 10.1073/pnas.90.15.7381 Goujon, 2007, SIVSM/HIV-2 Vpx proteins promote retroviral escape from a proteasome-dependent restriction pathway present in human dendritic cells, Retrovirology, 4, 2, 10.1186/1742-4690-4-2 Goulder, 2004, HIV and SIV CTL escape: implications for vaccine design, Nat. Rev. Immunol., 4, 630, 10.1038/nri1417 Gummuluru, 2000, An in vitro rapid-turnover assay for human immunodeficiency virus type 1 replication selects for cell-to-cell spread of virus, J. Virol., 74, 10882, 10.1128/JVI.74.23.10882-10891.2000 Haller, 2006, The HIV-1 pathogenicity factor Nef interferes with maturation of stimulatory T-lymphocyte contacts by modulation of N-Wasp activity, J. Biol. Chem., 281, 19618, 10.1074/jbc.M513802200 Harris, 2004, Retroviral restriction by APOBEC proteins, Nat. Rev. Immunol., 4,, 868, 10.1038/nri1489 Holmes, 2007, APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G, J. Biol. Chem., 282, 2587, 10.1074/jbc.M607298200 Holmes, 2007, APOBEC-mediated viral restriction: not simply editing?, Trends Biochem. Sci., 32, 118, 10.1016/j.tibs.2007.01.004 Horvath, 2004, Weapons of STAT destruction. Interferon evasion by paramyxovirus V protein, Eur. J. Biochem., 271, 4621, 10.1111/j.1432-1033.2004.04425.x Howe, 1998, Zeta chain of the T-cell receptor interacts with nef of simian immunodeficiency virus and human immunodeficiency virus type 2, J. Virol., 72, 9827, 10.1128/JVI.72.12.9827-9834.1998 Hrecka, 2007, Lentiviral Vpr usurps Cul4–DDB1[VprBP] E3 ubiquitin ligase to modulate cell cycle, Proc. Natl. Acad. Sci. USA, 104, 11778, 10.1073/pnas.0702102104 Huang, 2007, Derepression of microRNA-mediated protein translation inhibition by apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G (APOBEC3G) and its family members, J. Biol. Chem., 282, 33632, 10.1074/jbc.M705116200 Huthoff, 2007, Identification of amino acid residues in APOBEC3G required for regulation by human immunodeficiency virus type 1 Vif and Virion encapsidation, J. Virol., 81, 3807, 10.1128/JVI.02795-06 Iwatani, 2007, Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G, Nucleic Acids Res., 35, 7096, 10.1093/nar/gkm750 Janini, 2001, Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4(+) T cells, J. Virol., 75, 7973, 10.1128/JVI.75.17.7973-7986.2001 Jarmuz, 2002, An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22, Genomics, 79, 285, 10.1006/geno.2002.6718 Jern, 2007, Role of APOBEC3 in genetic diversity among endogenous murine leukemia viruses, PLoS Genet., 3, 2014, 10.1371/journal.pgen.0030183 Kaiser, 2006, Uracil DNA glycosylase is dispensable for human immunodeficiency virus type 1 replication and does not contribute to the antiviral effects of the cytidine deaminase Apobec3G, J. Virol., 80, 875, 10.1128/JVI.80.2.875-882.2006 Keele, 2008, Identification and Characterization of Transmitted and Early Founder Virus Envelopes in Primary HIV-1 Infection, Proc. Natl. Acad. Sci. USA, 10.1073/pnas.0802203105 Kozak, 2006, The anti-HIV-1 editing enzyme APOBEC3G binds HIV-1 RNA and messenger RNAs that shuttle between polysomes and stress granules, J. Biol. Chem., 281, 29105, 10.1074/jbc.M601901200 Kupzig, 2003, Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology, Traffic, 4, 694, 10.1034/j.1600-0854.2003.00129.x Lai, 2005, Activation of the ATR pathway by human immunodeficiency virus type 1 Vpr involves its direct binding to chromatin in vivo, J. Virol., 79, 15443, 10.1128/JVI.79.24.15443-15451.2005 Lama, 1999, Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner, Curr. Biol., 9, 622, 10.1016/S0960-9822(99)80284-X Langlois, 2008, Human APOBEC3G can restrict retroviral infection in avian cells and acts independently of both UNG and SMUG1, J. Virol., 82, 4660, 10.1128/JVI.02469-07 Le Rouzic, 2007, HIV1 Vpr arrests the cell cycle by recruiting DCAF1/VprBP, a receptor of the Cul4–DDB1 ubiquitin ligase, Cell Cycle, 6, 182, 10.4161/cc.6.2.3732 Lewis, 2008, Functional Adaptation of Nef to the Immune Milieu of HIV-1 Infection In Vivo, J. Immunol., 180, 4075, 10.4049/jimmunol.180.6.4075 Liu, 2005, Regulation of Apobec3F and human immunodeficiency virus type 1 Vif by Vif-Cul5-ElonB/C E3 ubiquitin ligase, J. Virol., 79, 9579, 10.1128/JVI.79.15.9579-9587.2005 Lubben, 2007, HIV-1 Nef-induced down-regulation of MHC class I requires AP-1 and clathrin but not PACS-1 and is impeded by AP-2, Mol. Biol. Cell, 18, 3351, 10.1091/mbc.E07-03-0218 Margottin, 1998, A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif, Mol. Cell, 1, 565, 10.1016/S1097-2765(00)80056-8 Mbisa, 2007, Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration, J. Virol., 81, 7099, 10.1128/JVI.00272-07 Mehle, 2004, Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation, Genes Dev., 18, 2861, 10.1101/gad.1249904 Mehle, 2006, A zinc-binding region in Vif binds Cul5 and determines cullin selection, J. Biol. Chem., 281, 17259, 10.1074/jbc.M602413200 Meusser, 2004, Vpu-mediated degradation of CD4 reconstituted in yeast reveals mechanistic differences to cellular ER-associated protein degradation, Mol. Cell, 14, 247, 10.1016/S1097-2765(04)00212-6 Miyagi, 2007, Enzymatically active APOBEC3G is required for efficient inhibition of human immunodeficiency virus type 1, J. Virol., 81, 13346, 10.1128/JVI.01361-07 Muthumani, 2005, Human immunodeficiency virus type 1 (HIV-1) Vpr-regulated cell death: insights into mechanism, Cell Death Differ., 12, 962, 10.1038/sj.cdd.4401583 Neil, 2006, HIV-1 Vpu promotes release and prevents endocytosis of nascent retrovirus particles from the plasma membrane, PLoS Pathog., 2, e39, 10.1371/journal.ppat.0020039 Neil, 2007, An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein, Cell Host Microbe, 2, 193, 10.1016/j.chom.2007.08.001 Neil, 2008, Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu, Nature, 451, 425, 10.1038/nature06553 Newman, 2005, Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity, Curr. Biol., 15, 166, 10.1016/j.cub.2004.12.068 Noviello, 2008, Cooperative binding of the class I major histocompatibility complex cytoplasmic domain and human immunodeficiency virus type 1 Nef to the endosomal AP-1 complex via its mu subunit, J. Virol., 82, 1249, 10.1128/JVI.00660-07 Pandrea, 2008, Simian Immunodeficiency Virus SIVagm Dynamics in African Green Monkeys, J. Virol., 82, 3713, 10.1128/JVI.02402-07 Petroski, 2005, Function and regulation of cullin-RING ubiquitin ligases, Nat. Rev. Mol. Cell Biol., 6, 9, 10.1038/nrm1547 Pizzato, 2007, Dynamin 2 is required for the enhancement of HIV-1 infectivity by Nef, Proc. Natl. Acad. Sci. USA, 104, 6812, 10.1073/pnas.0607622104 Roeth, 2006, Human immunodeficiency virus type 1 Nef: adapting to intracellular trafficking pathways, Microbiol. Mol. Biol. Rev., 70, 548, 10.1128/MMBR.00042-05 Roeth, 2004, HIV-1 Nef disrupts MHC-I trafficking by recruiting AP-1 to the MHC-I cytoplasmic tail, J. Cell Biol., 167, 903, 10.1083/jcb.200407031 Rollason, 2007, Clathrin-mediated endocytosis of a lipid-raft-associated protein is mediated through a dual tyrosine motif, J. Cell Sci., 120, 3850, 10.1242/jcs.003343 Ross, 1999, Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein, Curr. Biol., 9, 613, 10.1016/S0960-9822(99)80283-8 Russell, 2007, Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F, J. Virol., 81, 8201, 10.1128/JVI.00395-07 Sakai, 2006, The Vif and Vpr accessory proteins independently cause HIV-1-induced T cell cytopathicity and cell cycle arrest, Proc. Natl. Acad. Sci. USA, 103, 3369, 10.1073/pnas.0509417103 Sawyer, 2004, Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G, PLoS Biol., 2, E275, 10.1371/journal.pbio.0020275 Sawyer, 2006, Positive selection of yeast nonhomologous end-joining genes and a retrotransposon conflict hypothesis, Proc. Natl. Acad. Sci. USA, 103, 17614, 10.1073/pnas.0605468103 Schindler, 2006, Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1, Cell, 125, 1055, 10.1016/j.cell.2006.04.033 Schrofelbauer, 2007, HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1, Proc. Natl. Acad. Sci. USA, 104, 4130, 10.1073/pnas.0610167104 Schubert, 1996, The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains, J. Virol., 70, 809, 10.1128/JVI.70.2.809-819.1996 Schumacher, 2008, The DNA deaminase activity of human APOBEC3G is required for Ty1, MusD, and human immunodeficiency virus type 1 restriction, J. Virol., 82, 2652, 10.1128/JVI.02391-07 Sharova, 2008, Primate lentiviral Vpx commandeers DDB1 to counteract a macrophage restriction, PLoS Pathog., 4, e1000057, 10.1371/journal.ppat.1000057 Sheehy, 2002, Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein, Nature, 418, 646, 10.1038/nature00939 Simon, 2005, Natural variation in Vif: differential impact on APOBEC3G/3F and a potential role in HIV-1 diversification, PLoS Pathog., 1, e6, 10.1371/journal.ppat.0010006 Soros, 2007, Newly synthesized APOBEC3G is incorporated into HIV virions, inhibited by HIV RNA, and subsequently activated by RNase H, PLoS Pathog., 3, e15, 10.1371/journal.ppat.0030015 Specht, 2008, Selective downmodulation of HLA-A and -B by Nef alleles from different groups of primate lentiviruses, Virology, 373, 229, 10.1016/j.virol.2007.11.019 Srivastava, 2008, Lentiviral Vpx accessory factor targets VprBP/DCAF1 substrate adaptor for Cullin 4 E3 ubiquitin ligase to enable macrophage infection, PLoS Pathog., 4, e1000059, 10.1371/journal.ppat.1000059 Swanson, 2008, SnapShot: HIV-1 Proteins, Cell, 133, 742, 10.1016/j.cell.2008.05.005 Swigut, 2004, Impact of Nef-mediated downregulation of major histocompatibility complex class I on immune response to simian immunodeficiency virus, J. Virol., 78, 13335, 10.1128/JVI.78.23.13335-13344.2004 Tan, 2007, DDB1 and Cul4A are required for human immunodeficiency virus type 1 Vpr-induced G2 arrest, J. Virol., 81, 10822, 10.1128/JVI.01380-07 Thielen, 2007, T cells contain an RNase-insensitive inhibitor of APOBEC3G deaminase activity, PLoS Pathog., 3, 1320, 10.1371/journal.ppat.0030135 Thoulouze, 2006, Human immunodeficiency virus type-1 infection impairs the formation of the immunological synapse, Immunity, 24, 547, 10.1016/j.immuni.2006.02.016 Tian, 2006, Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F, J. Virol., 80, 3112, 10.1128/JVI.80.6.3112-3115.2006 Towers, 2007, The control of viral infection by tripartite motif proteins and cyclophilin A, Retrovirology, 4, 40, 10.1186/1742-4690-4-40 Van Damme, 2008, The interferon-induced protein BST-2 restricts HIV-1 release and Is downregulated from the cell surface by the viral Vpu protein, Cell Host Microbe, 3, 1, 10.1016/j.chom.2008.03.001 Vartanian, 2008, Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions, Science, 320, 230, 10.1126/science.1153201 Varthakavi, 2003, Viral protein U counteracts a human host cell restriction that inhibits HIV-1 particle production, Proc. Natl. Acad. Sci. USA, 100, 15154, 10.1073/pnas.2433165100 Varthakavi, 2006, The pericentriolar recycling endosome plays a key role in Vpu-mediated enhancement of HIV-1 particle release, Traffic, 7, 298, 10.1111/j.1600-0854.2005.00380.x Wen, 2007, The HIV1 protein Vpr acts to promote G2 cell cycle arrest by engaging a DDB1 and Cullin4A-containing ubiquitin ligase complex using VprBP/DCAF1 as an adaptor, J. Biol. Chem., 282, 27046, 10.1074/jbc.M703955200 Wichroski, 2006, Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodies, PLoS Pathog., 2, e41, 10.1371/journal.ppat.0020041 Yamashita, 2005, The cell cycle independence of HIV infections is not determined by known karyophilic viral elements, PLoS Pathog., 1, e18, 10.1371/journal.ppat.0010018 Yu, 2003, Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex, Science, 302, 1056, 10.1126/science.1089591 Yu, 2004, Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines, Genes Dev., 18, 2867, 10.1101/gad.1250204 Zimmerman, 2004, Human immunodeficiency virus type 1 Vpr-mediated G2 arrest requires Rad17 and Hus1 and induces nuclear BRCA1 and gamma-H2AX focus formation, Mol. Cell. Biol., 24, 9286, 10.1128/MCB.24.21.9286-9294.2004 Zimmerman, 2006, Human immunodeficiency virus type 1 Vpr induces DNA replication stress in vitro and in vivo, J. Virol., 80, 10407, 10.1128/JVI.01212-06